The Impact of Fermented Milk Products on Gut Microbiota‐Derived Metabolites in Obesity: A Narrative Review
Journal of Food Science · 2025-06 · 90 (6)
DOI: 10.1111/1750-3841.70301 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Food Science, online erschienen am 06.06.2025. Verfasst von Tsamaroh Azzah Mukarromah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Science, Faculty of Medicine, Universitas Diponegoro, Tembalang, Semarang, Indonesia. Hauptthemen laut MEDLINE: Obesity, Gastrointestinal Microbiome, Cultured Milk Products. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 205 Literaturangaben.
Abstract (Originalsprache)
Obesity, a multifactorial metabolic disorder, has been increasingly linked to gut microbiota dysbiosis and its downstream metabolites. Among these, short‐chain fatty acids (SCFAs) and secondary bile acids (SBAs) play pivotal roles in energy regulation, glucose and lipid metabolism, inflammation, and host‐microbiota crosstalk. Fermented milk products, enriched with probiotics, prebiotics, and bioactive peptides, offer a dietary intervention capable of modulating the gut microbial community and promoting the production of beneficial metabolites. This narrative review synthesizes evidence from both animal and human studies to explore the influence of fermented milk products on SCFA and SBA production in the context of obesity. Findings suggest that fermented milk consumption enhances the abundance of beneficial bacteria (e.g., Lactobacillus, Bifidobacterium), increases SCFA and SBA levels, improves intestinal barrier function, and contributes to improved metabolic outcomes, including reduced inflammation, improved insulin sensitivity, and favorable lipid profiles. These effects are mediated through key molecular pathways involving free fatty acid receptors, bile acid receptors, and inflammatory mediators. Further long‐term, mechanistic, and population‐diverse studies are essential to optimize formulations and substantiate clinical applications of fermented milk in obesity management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition Science, Faculty of Medicine, Universitas Diponegoro, Tembalang, Semarang, Indonesia.
- Department of Pharmacology and Therapeutic, Faculty of Medicine, Universitas Diponegoro, Tembalang, Semarang, Indonesia.
- Department of Biology, Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Indonesia.
ORCID-Profile: Ninik Rustanti, Endang Mahati, Suparmi, Fitriyono Ayustaningwarno
Zitieren
APA
Mukarromah, T. A., Rustanti, N., Mahati, E., Suparmi, & Ayustaningwarno, F. (2025). The Impact of Fermented Milk Products on Gut Microbiota‐Derived Metabolites in Obesity: A Narrative Review. Journal of Food Science, 90(6). https://doi.org/10.1111/1750-3841.70301
Vancouver
Mukarromah TA, Rustanti N, Mahati E, Suparmi, Ayustaningwarno F. The Impact of Fermented Milk Products on Gut Microbiota‐Derived Metabolites in Obesity: A Narrative Review. Journal of Food Science. 2025;90(6). doi:10.1111/1750-3841.70301
BibTeX
@article{Mukarromah2025,
author = {Mukarromah, Tsamaroh Azzah and Rustanti, Ninik and Mahati, Endang and Suparmi and Ayustaningwarno, Fitriyono},
title = {The Impact of Fermented Milk Products on Gut Microbiota‐Derived Metabolites in Obesity: A Narrative Review},
journal = {Journal of Food Science},
year = {2025},
volume = {90},
number = {6},
doi = {10.1111/1750-3841.70301}
}
EUVIMED